Literature DB >> 12767990

Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism.

Yida Yang1, Ilia Tikhonov, Tracy J Ruckwardt, Mahmoud Djavani, Juan Carlos Zapata, C David Pauza, Maria S Salvato.   

Abstract

The human immunodeficiency virus (HIV) Tat protein has a critical role in viral transcription, but this study focuses on its additional role as an extracellular effector of lymphocyte cell death. It is well known that Tat induces tumor necrosis factor-related apoptosis-induced ligand (TRAIL) in peripheral blood mononuclear cells (PBMC), and we show that the majority of TRAIL is produced by the monocyte subset of PBMC. Human monocytes and U937 monoblastoid cells did not take up soluble HIV Tat-86, as T cells did, yet produced more TRAIL than did T cells. TRAIL secretion was induced by Tat and by a cysteine-rich peptide of Tat but not by sulfhydryl-modified Tat toxoid. Although there was only a slight increase in cell surface expression of TRAIL on monocytes, sufficient TRAIL was secreted to be toxic for T cells. The cytotoxicity of Tat-stimulated monocyte medium could be blocked by a TRAIL-neutralizing antibody. T cells treated with Tat did not secrete enough TRAIL to mediate cell death in our assay. Remarkably, uninfected T cells are more susceptible to TRAIL than are HIV-infected T cells. The production of TRAIL by Tat-stimulated monocytes provides a mechanism by which HIV infection can destroy uninfected bystander cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767990      PMCID: PMC156176          DOI: 10.1128/jvi.77.12.6700-6708.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use.

Authors:  H Le Buanec; B Bizzini
Journal:  Biomed Pharmacother       Date:  2000-02       Impact factor: 6.529

2.  HIV-1 Tat protein mimicry of chemokines.

Authors:  A Albini; S Ferrini; R Benelli; S Sforzini; D Giunciuglio; M G Aluigi; A E Proudfoot; S Alouani; T N Wells; G Mariani; R L Rabin; J M Farber; D M Noonan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

3.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  M Jo; T H Kim; D W Seol; J E Esplen; K Dorko; T R Billiar; S C Strom
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

4.  Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages.

Authors:  O Halaas; R Vik; A Ashkenazi; T Espevik
Journal:  Scand J Immunol       Date:  2000-03       Impact factor: 3.487

5.  Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques.

Authors:  M Wallace; P M Waterman; J L Mitchen; M Djavani; C Brown; P Trivedi; D Horejsh; M Dykhuizen; M Kitabwalla; C D Pauza
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway.

Authors:  A Badou; Y Bennasser; M Moreau; C Leclerc; M Benkirane; E Bahraoui
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  G Kothny-Wilkes; D Kulms; B Pöppelmann; T A Luger; M Kubin; T Schwarz
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

8.  Dissemination of lymphocytic choriomeningitis virus from the gastric mucosa requires G protein-coupled signaling.

Authors:  C Yin; M Djavani; A R Schenkel; D S Schmidt; C D Pauza; M S Salvato
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.

Authors:  M J Martínez-Lorenzo; M A Alava; S Gamen; K J Kim; A Chuntharapai; A Piñeiro; J Naval; A Anel
Journal:  Eur J Immunol       Date:  1998-09       Impact factor: 5.532

10.  Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.

Authors:  C D Pauza; P Trivedi; M Wallace; T J Ruckwardt; H Le Buanec; W Lu; B Bizzini; A Burny; D Zagury; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  35 in total

1.  Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets.

Authors:  Theodore J Cory; Hui He; Lee C Winchester; Santosh Kumar; Courtney V Fletcher
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

Review 2.  HIV-1 immunopathogenesis: how good interferon turns bad.

Authors:  Jean-Philippe Herbeuval; Gene M Shearer
Journal:  Clin Immunol       Date:  2006-11-16       Impact factor: 3.969

3.  Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes.

Authors:  Lin Zheng; Yi-da Yang; Guo-cai Lu; Maria S Salvato
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

4.  FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.

Authors:  Liv Eidsmo; Caroline Fluur; Bence Rethi; Sofia Eriksson Ygberg; Nicolas Ruffin; Angelo De Milito; Hannah Akuffo; Francesca Chiodi
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 5.  The TRAIL to viral pathogenesis: the good, the bad and the ugly.

Authors:  Nathan Cummins; Andrew Badley
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

6.  Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection.

Authors:  Mareike Meythaler; Amanda Martinot; Zichun Wang; Sarah Pryputniewicz; Melissa Kasheta; Binhua Ling; Preston A Marx; Shawn O'Neil; Amitinder Kaur
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

7.  Anti-apoptotic genes in the survival of monocytic cells during infection.

Authors:  Aurelia Busca; Mansi Saxena; Marko Kryworuchko; Ashok Kumar
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

8.  HIV Tat potentiates cell toxicity in a T cell model for sulphamethoxazole-induced adverse drug reactions.

Authors:  Kemi Adeyanju; Adriana Krizova; Philippe A Gilbert; Gregory A Dekaban; Michael Rieder
Journal:  Virus Genes       Date:  2009-03-10       Impact factor: 2.332

9.  Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages.

Authors:  Yunlong Huang; Angelique Walstrom; Luwen Zhang; Yong Zhao; Min Cui; Ling Ye; Jialin C Zheng
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

Review 10.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.